Enhancing precision in sarcoma diagnosis: nCounter fusion panel implementation in a middle-income country
Although it does not identify all sarcoma fusions, especially for rare subtypes, the present nCounter assay is a rapid, affordable, and accurate tool for sarcoma diagnosis in resource-limited settings.
Authors
- Karla Emília de Sá Rodrigues (ORCID: https://orcid.org/0000-0002-3306-4890)
- Léon C.L.T. van Kempen (ORCID: https://orcid.org/0000-0003-0646-0705)
- Gustavo Ramos Teixeira (ORCID: https://orcid.org/0000-0001-8363-3513)
- Rui Manuel Reis (ORCID: https://orcid.org/0000-0002-9639-7940)
- Murilo Bonatelli (ORCID: https://orcid.org/0000-0002-7607-5119)
- Flavia Paula (ORCID: https://orcid.org/0009-0001-9236-990X)
- Monise Tadin Reis (ORCID: https://orcid.org/0009-0001-5708-9881)
Institutions
- University Medical Center Groningen (NL)
- University of Antwerp (BE)
- University of Groningen (NL)
- Hospital de Câncer de Barretos (BR)
- Antwerp University Hospital (BE)
- University of Minho (PT)
Publication Details
- Journal
- Therapeutic Advances in Medical Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17588359251318159
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00